DECOMPOSITION AND MODIFICATION OF SILICATE AND SILICONE BY SILASE AND USE OF THE REVERSIBLE ENZYME

Details for Australian Patent Application No. 2003276044 (hide)

Owner JOHANNES GUTENBERG-UNIVERSITAT MAINZ

Inventors Krasko, Anatoli; Muller, Werner E G.; Schroder, Heinz

Agent Pizzeys

Pub. Number AU-A-2003276044

PCT Number PCT/EP03/10983

PCT Pub. Number WO2004/033679

Priority 102 46 186.4 03.10.02 DE

Filing date 2 October 2003

Wipo publication date 4 May 2004

International Classifications

C12N 009/88 Enzymes, e.g. ligases (6.) - Lyases (4.)

C12N 015/11 Mutation or genetic engineering - DNA or RNA fragments

G01N 033/50 Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

C12N 015/62 Mutation or genetic engineering - DNA sequences coding for fusion proteins

C12N 015/60 Mutation or genetic engineering - Lyases (4)

C12P 003/00 Preparation of elements or inorganic compounds except carbon dioxide

Event Publications

19 February 2004 Complete Application Filed

  Priority application(s): 102 46 186.4 03.10.02 DE

3 June 2004 Application Open to Public Inspection

  Published as AU-A-2003276044

30 April 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003276045-METHOD OF SOLVING A SPLITBRAIN CONDITION

2003276043-1-((5-ARYL-1,2,4-OXADIAZOL-3-YL)B ENZYL)AZETIDINE-3-CARBOXYLATES AND 1-((5-ARYL-1,2,4-OXADIAZOL-3-YL)B ENZYL)PYRROLIDINE-3-CARBOXYLATE S AS EDG RECEPTOR AGONISTS